Pathways, which has drawn anemic enrollment ahead of its scheduled expiration next year, is the subject of an intense legal and philosophical battle over the future of Medicaid, a joint federal-state program that accounts for roughly 10 percent of the federal budget and covers around 75 million Americans, most of them lower income.